financetom
Business
financetom
/
Business
/
Enovix Stock Soars On Blockbuster Q1 Sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enovix Stock Soars On Blockbuster Q1 Sales
May 1, 2024 2:42 PM

Enovix Corporation ( ENVX ) reported its first-quarter financial results after the bell Wednesday. Here's a look at the highlights. 

The Details: Enovix ( ENVX ) reported quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 29 cents by 6.9%.

Quarterly sales clocked in at $5.272 million, beating the analyst consensus estimate of $3.779 million by 39.53% and representing a large increase over sales of $21,000 from the same period last year.

Enovix ( ENVX ) said stronger revenues and a favorable product mix helped the company achieve positive non-GAAP gross margins for the first time in its history.

“We are off to a strong start in 2024, with Fab2 scheduled to begin battery production and final EX-1M batteries ready for sampling in the second quarter. Our customer relationships have grown even stronger as leading OEMs are eager to be first to market with a high-energy battery cell capable of using a 100% active silicon anode,” the company said.

The company also announced it has reached a development agreement with one of the top five smartphone OEMs in the world by unit volume.

“We are thrilled to announce we have advanced our engagement further with one of our top customers by reaching a formal development agreement, underscoring the value and competitive advantage our silicon batteries can provide to the next generation of smartphones, beginning with EX-1M,” said Dr. Raj Talluri, president and CEO, Enovix ( ENVX ).

Outlook:  Enovix ( ENVX ) sees second-quarter revenue between $3 million and $4 million, an adjusted EBITDA loss of $26 million to $32 million and a non-GAAP loss of between 22 cents and 28 cents per share.

ENVX Price Action: According to Benzinga Pro, Enovix ( ENVX ) shares are up 21.35 % after-hours at $7.90 at the time of publication Wednesday.

Related News: What’s Going On With Super Micro Stock After Earnings?

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla Adds Lower-Priced Cybertruck Model in the US
Tesla Adds Lower-Priced Cybertruck Model in the US
Apr 11, 2025
06:28 AM EDT, 04/11/2025 (MT Newswires) -- Tesla (TSLA) rolled out Friday a new long-range version of its Cybertruck for US buyers. The vehicle is listed at $69,990, making it the least expensive of the three Cybertruck options currently offered in the country, according to the site. The total price does not include most of the most recognizable features such...
Market Chatter: Chevron Oil-Loading Authorizations Suspended by Venezuela's PDVSA
Market Chatter: Chevron Oil-Loading Authorizations Suspended by Venezuela's PDVSA
Apr 11, 2025
06:28 AM EDT, 04/11/2025 (MT Newswires) -- Chevron's ( CVX ) operations in Venezuela are facing disruptions after state oil company PDVSA canceled several authorizations it had granted to the US-based company to load and export Venezuelan crude, Reuters reported, citing three sources with knowledge of the decision. Two of the cargos cancelled by PDVSA involve tankers that had already...
China's JD.com to spend $27 billion to help exporters go domestic amid trade war
China's JD.com to spend $27 billion to help exporters go domestic amid trade war
Apr 11, 2025
BEIJING, April 11 (Reuters) - China's e-commerce giant JD.com ( JD ) said on Friday it will launch a 200 billion yuan ($27.35 billion) fund to help the country's exporters sell their products domestically over the next year, as a U.S.-China trade war intensifies. Beijing increased its tariffs on U.S. imports on Friday to 125%, hitting back against U.S. President...
Oncolytics Up 1.5% in U.S. Pre-market as Funds Pelareorep's Ongoing Clinical Development
Oncolytics Up 1.5% in U.S. Pre-market as Funds Pelareorep's Ongoing Clinical Development
Apr 11, 2025
06:28 AM EDT, 04/11/2025 (MT Newswires) -- Oncolytics Biotech ( ONCY ) , a clinical-stage company specializing in immunotherapy for oncology, was at last look up 1.5% from near 52 week low levels in U.S. pre-market trading on Friday after it signed a share purchase agreement (SPA) with Alumni Capital LP (Alumni), an institutional investor. According to a statement released...
Copyright 2023-2025 - www.financetom.com All Rights Reserved